Naturally occurring polyamine · Fact sheet

Spermidine

Also known as dietary spermidine · polyamine

Spermidine is a real cellular metabolite and a plausible autophagy research target, but it is not an FDA-approved drug for cognitive decline or aging. A 12-month randomized trial in older adults did not improve its primary memory outcome.

Not FDA approvedEarly human evidence

What is Spermidine?

Spermidine is a polyamine involved in cell growth, protein function, and cellular maintenance. It occurs in human cells and in foods.

Laboratory and animal findings connect spermidine with autophagy and lifespan biology, but those findings do not establish a human anti-aging effect.

Benefits & claims

Autophagy is a core cellular recycling process, and dietary observational studies have linked higher spermidine intake with some favorable outcomes.

Observational diet patterns can carry many confounders, so randomized trials are essential.

What the evidence supports

  • A small pilot generated a possible memory signal that justified a larger trial.
  • The larger SmartAge trial did not confirm a significant improvement in the primary memory outcome, although exploratory biomarker work continues.
Research areas
  • Memory in subjective cognitive decline
  • Autophagy-related biomarkers
  • Cardiometabolic and healthy-aging associations
  • Dietary polyamine biology

Dosage & frequency

Human study context

Spermidine trials use defined supplement formulations and have not established a cognitive-aging or longevity prescription.

SmartAge randomized trial

100 adults age 60–90 with subjective cognitive decline

Amount
Wheat-germ extract supplying 0.9 mg spermidine/day
Frequency
Daily for twelve months
Route studied or labeled
Oral

Primary memory outcome did not significantly improve; extract is not purified spermidine.

How to read these amounts

An approved regimen belongs to a specific product, indication, and population. A study regimen describes what researchers tested; it does not establish a prescription or a safe self-use protocol. Products, routes, and formulations are not interchangeable. A prescriber uses the full label and individual clinical circumstances.

Personal accounts may describe amounts, schedules and outcomes beyond clinical research. They do not establish a regimen. Read the reported experiences

Formulations, interactions & practical context

Formulation differences

  • Spermidine-rich extracts and purified spermidine are not necessarily equivalent exposures.

Interactions & precautions

  • The wheat-germ extract trial does not establish interactions for purified spermidine or arbitrary high-exposure supplement combinations.

What is still unresolved

  • Meaningful clinical benefit, optimal exposure, and long-term safety remain uncertain.

Side effects & risks

  • The studied food-extract formulation was generally tolerated, but available trials are not large enough for uncommon harms.
  • A supplement extract is not interchangeable with dietary intake or endogenous spermidine biology.
  • Commercial product composition and labeling may vary.

This is a summary of the cited evidence, not a complete product label. A lack of human safety data does not establish safety.

Clinical research

Early human evidence

Human observational evidence and small trials generated interest, but the phase 2b SmartAge trial did not show a significant benefit on its primary memory endpoint after 12 months.

Studies

Personal experiences

Reports describe what someone noticed. They cannot establish cause, typical results, or how often a side effect happens. Amounts and schedules describe the individual account, not an effective or safe dose. Product identity and strength may be unverified, and missing details are left explicit.

Explore 3 sourced accounts by reported effect.

Appetite: reported experiences

Mixed account · personal report

More energy, but nausea and less appetite

An author described unusually high energy and earlier waking, alongside nausea, reduced appetite and more saliva. Some sensations continued several days after stopping.

Reported use in this account

Product
Product labeled spermidine capsules
Amount
10 mg, as reported
Frequency
Daily
Route
Oral capsules
Duration
Several days, estimated by the author as five

Other exposures described: ALCAR; Creatine; Beta-alanine; DIM; Folate; Electrolytes; Omega-3 fatty acids; Vitamin D; Magnesium glycinate

This brief account also mentions magnesium. The author's proposed biological explanation is unverified.

Read the original account

Approval status

Spermidine is not an FDA-approved drug for memory, cognitive decline, dementia prevention, autophagy enhancement, or aging. Dietary supplements are not preapproved by FDA for effectiveness.

No FDA-approved cognitive or aging use

Spermidine has dietary and supplement research, including a negative primary memory outcome in a Phase 2b cognitive trial, but no FDA-approved drug use.

Approval covers the labeled product, use and population. A trial phase does not establish success; a stopped program is not ongoing research.

Open questions

  • Whether another population or outcome would show a reproducible benefit
  • Whether supplement exposure meaningfully changes autophagy in relevant human tissues
  • Long-term safety and interaction effects
  • Whether observational diet associations are causal

Summary

A 12-month trial did not improve its primary memory outcome. Autophagy mechanisms do not establish cognitive or longevity benefits.

Sources

Medical evidence and regulatory sources are listed here. Personal reports are linked separately in the experiences section.

  1. pubmedSmartAge randomized clinical trial

    Phase 2b trial reporting no significant improvement in its primary memory endpoint.

  2. pubmedSmartAge trial protocol

    Prospective protocol defining the trial design and planned cognitive outcomes.

  3. pubmedMechanisms of spermidine-related autophagy research

    Peer-reviewed mechanistic review that helps separate biological rationale from clinical proof.

  4. fdaFDA: what ‘FDA approved’ does and does not mean

    FDA explains that dietary supplements are not approved for safety and effectiveness before marketing.

How we assess sources · Suggest a correction